Oppenheimer Appoints James Yoo Managing Director in Healthcare Equity Capital Markets Investment Banking
Oppenheimer (NYSE: OPY) announced on October 6, 2025 that James Yoo was named Managing Director in its Healthcare Equity Capital Markets Investment Banking Group.
The company states Mr. Yoo brings 27 years of industry experience and will focus on biotechnology equity capital markets, including PIPEs, follow-on offerings, CMPOs and registered direct transactions. According to the PR, Yoo previously served as Oppenheimer's Healthcare Specialist on the Sales & Trading desk since 2023 and held roles at Piper Sandler, Mizuho, and Nomura. Management comments in the release highlight Yoo's execution track record and biotech relationships as strengthening Oppenheimer's Healthcare ECM platform.
Oppenheimer (NYSE: OPY) ha annunciato il 6 ottobre 2025 che James Yoo è stato nominato Managing Director nel suo Healthcare Equity Capital Markets Investment Banking Group.
La società afferma che il signor Yoo porta 27 anni di esperienza nel settore e si concentrerà su capital markets di biotecnologia, inclusi PIPE, offerte successive, CMPO e transazioni dirette registrate. Secondo il comunicato, Yoo ha precedentemente ricoperto il ruolo di Healthcare Specialist presso la Sales & Trading di Oppenheimer dal 2023 e ha ricoperto ruoli in Piper Sandler, Mizuho e Nomura. I commenti della direzione nel comunicato evidenziano la sua comprovata capacità di esecuzione e le relazioni nel biotech come elementi che rafforzano la piattaforma Healthcare ECM di Oppenheimer.
Oppenheimer (NYSE: OPY) anunció el 6 de octubre de 2025 que James Yoo fue nombrado Managing Director en su Healthcare Equity Capital Markets Investment Banking Group.
La empresa afirma que el Sr. Yoo aporta 27 años de experiencia en la industria y se enfocará en los mercados de capital de biotecnología, incluyendo PIPE, ofertas de seguimiento, CMPO y transacciones directas registradas. Según el comunicado, Yoo se desempeñó previamente como Healthcare Specialist en el escritorio de Ventas y Trading desde 2023 y ocupó cargos en Piper Sandler, Mizuho y Nomura. Los comentarios de la dirección en el comunicado destacan la trayectoria de ejecución de Yoo y sus relaciones en biotecnología como un fortalecimiento de la plataforma de Healthcare ECM de Oppenheimer.
Oppenheimer (NYSE: OPY)가 2025년 10월 6일 James Yoo가 헬스케어 주식자본시장 투자은행 그룹의 Managing Director로 임명되었다고 발표했습니다.
회사는 Yoo가 업계에서 27년의 경력을 보유하고 있으며 생명공학 주식자본시장에 초점을 맞출 것이라고 밝혔으며, PIPE, 후속공모, CMPO 및 등록된 직거래를 포함합니다. 보도자료에 따르면 Yoo는 2023년부터 Oppenheimer의 헬스케어 스페셜리스트로 세일즈&트레이딩 데스크에서 근무했고 Piper Sandler, Mizuho 및 Nomura에서 근무한 경력이 있습니다. 발표의 경영진 코멘트는 Yoo의 실행 실적과 바이오테크 관계가 Oppenheimer의 헬스케어 ECM 플랫폼을 강화한다고 강조합니다.
Oppenheimer (NYSE: OPY) a annoncé le 6 octobre 2025 que James Yoo a été nommé Managing Director au sein de son Healthcare Equity Capital Markets Investment Banking Group.
La société indique que M. Yoo apporte 27 ans d'expérience dans l'industrie et se concentrera sur les marchés de capitaux propres en biotechnologie, y compris les PIPE, les offres de suivi, les CMPO et les transactions directes enregistrées. Selon le communiqué, Yoo a auparavant occupé le poste de Healthcare Specialist sur le desk Sales & Trading d'Oppenheimer depuis 2023 et a occupé des postes chez Piper Sandler, Mizuho et Nomura. Les commentaires de la direction dans le communiqué soulignent le parcours d'exécution de Yoo et ses relations dans le domaine biotech comme un renforcement de la plateforme Healthcare ECM d'Oppenheimer.
Oppenheimer (NYSE: OPY) gab am 6. Oktober 2025 bekannt, dass James Yoo zum Managing Director in seiner Healthcare Equity Capital Markets Investment Banking Group ernannt wurde.
Das Unternehmen erklärt, dass Herr Yoo 27 Jahre Branchenerfahrung mitbringt und sich auf Biotechnologie-Equity-Capital-Markets konzentrieren wird, einschließlich PIPEs, Folgeemissionen, CMPOs und registrierter Direct-Transaktionen.
Laut der Pressemitteilung hatte Yoo zuvor als Healthcare Specialist am Sales & Trading Desk von Oppenheimer seit 2023 gearbeitet und Positionen bei Piper Sandler, Mizuho und Nomura bekleidet. Managementkommentare in der Mitteilung heben Yoo's Umsetzungsbilanz und Biotech-Beziehungen hervor und stärken Oppenheimers Healthcare ECM-Plattform.
أوبنهايمر (بورصة نيويورك: OPY) أعلنت في 6 أكتوبر 2025 أن James Yoo قد عُيّن مديراً تنفيذياً Managing Director في مجموعة أسواق رأس المال لحقوق المرافق الصحية (Healthcare Equity Capital Markets Investment Banking Group).
وتذكر الشركة أن السيد Yoo يجلب 27 عامًا من الخبرة الصناعية وسيتركز على أسواق رأس المال لعلوم الحياة في مجال التكنولوجيا الحيوية، بما في ذلك PIPEs وعروض المتابعة وCMPOs والمعاملات المباشرة المسجلة. وفقاً للبيان، كان Yoo يشغل سابقاً منصب Healthcare Specialist في قسم المبيعات والتداول منذ 2023 وتولى مناصب في Piper Sandler وMizuho وNomura. وتبرز تعليقات الإدارة في البيان سجل Yoo في التنفيذ وعلاقاته في مجال التكنولوجيا الحيوية كعامل يعزز منصة Healthcare ECM لدى Oppenheimer.
Oppenheimer (NYSE: OPY) 于 2025 年 10 月 6 日 宣布 James Yoo 已被任命为其 Healthcare Equity Capital Markets Investment Banking Group 的董事总经理。
公司表示 Yoo 先生带来 27 年 行业经验，将专注于 生物技术股本市场，包括 PIPE、后续发行、CMPO 和注册直接交易。新闻稿显示，Yoo 曾自 2023 年起担任 Oppenheimer 销售与交易部的 Healthcare Specialist，并曾在 Piper Sandler、Mizuho 和 Nomura 任职。公告中的管理层评论强调 Yoo 的执行记录及其在生物技术领域的关系将增强 Oppenheimer 的 Healthcare ECM 平台。
- None.
- None.
Seasoned industry professional brings 27 years of experience to expanding Healthcare platform
With 27 years of experience, Mr. Yoo has developed deep expertise in a range of financing structures, including Private Investment in Public Equity (PIPEs), Follow-on Offerings, Confidentially Marketed Public Offerings (CMPOs) and Registered Direct transactions.
"James brings an exceptional track record of execution and deep relationships across the biotechnology investment community to his new role," said Peter Bennett, Managing Director and Head of Equity Capital Markets Investment Banking at Oppenheimer. "His ability to navigate complex financing structures will further strengthen Oppenheimer's leadership in Healthcare Equity Capital Markets."
Before stepping into his new role, Mr. Yoo served as the Healthcare Specialist on Oppenheimer's Sales & Trading Desk since 2023, advising healthcare-dedicated investment funds and early- and late-stage biotechnology companies. Prior to Oppenheimer, he held various positions at leading firms such as Piper Sandler, Mizuho, and Nomura.
"I am honored to join Oppenheimer's Healthcare Equity Capital Markets Investment Banking Group at such an exciting time for the biotechnology sector," Yoo said. "The firm's collaborative culture and broad platform create an exceptional environment to deliver innovative capital markets solutions. I look forward to working with my colleagues to help biotech companies access the financing they need to advance groundbreaking science and improve patient outcomes."
About Oppenheimer Holdings Inc.
Oppenheimer Holdings Inc., through its Oppenheimer & Co. Inc. subsidiary, and related entities, provides a full range of wealth management, securities brokerage, and investment banking services to high-net-worth individuals, families, corporate executives, businesses, and institutions. For more information, please visit www.oppenheimer.com.
Media Contact:
Joseph Kuo / Michael Dugan
Haven Tower Group LLC
424 317 4851 or 424 317 4852
jkuo@haventower.com or mdugan@haventower.com
View original content:https://www.prnewswire.com/news-releases/oppenheimer-appoints-james-yoo-managing-director-in-healthcare-equity-capital-markets-investment-banking-302574286.html
SOURCE Oppenheimer & Co. Inc.
FAQ
Who is James Yoo and what role did Oppenheimer (OPY) announce on October 6, 2025?
What experience does James Yoo bring to Oppenheimer's Healthcare ECM team?
How long has James Yoo been at Oppenheimer before this promotion (OPY)?
Will James Yoo's appointment at Oppenheimer (OPY) change the firm's biotech coverage focus?
Does the press release state any financial targets or transactions tied to James Yoo's hiring at OPY?
Where can investors find more information about Oppenheimer's Healthcare Equity Capital Markets team and leadership changes?
